Skip to main content
. 2024 May 27;14(6):306. doi: 10.3390/metabo14060306

Table 2.

Demographic and clinical characteristics of 79 patients according to sarcopenia groups.

Absence of Sarcopenia (N = 27) Probable Sarcopenia (N = 20) Confirmed Sarcopenia (N = 32) p-Value
Females N (%) 8 (29.6%) 9 (45%) 16 (50%) 0.2
Age (years) 74.7 ± 1.5 * 78.3 ± 1.5 81.0 ± 1.4 * 0.01
BMI (kg/m2) 26.3 ± 1.1 29.7 ± 1.7 25.8 ± 1.0 0.13
Underweight N (%) 2 (7.4%) 0 (0.0%) 2 (6.3%) 0.1
Normal weight N (%) 8 (29.6%) 8 (40.0%) 14 (43.8%) 0.1
Overweight N (%) 11 (40.7%) 10 (10.0%) 8 (25.0%) 0.1
Obese N (%) 6 (22.2%) 20 (50.0%) 8 (25.0%) 0.1
Comorbidities N (%)
Dyslipidemia 18 (66.7%) 11 (55.0%) 21 (65.6%) 0.6
Arterial Hypertension 18 (66.7%) 14 (70.0%) 25 (78.1%) 0.6
Thyroid disease 4 (14.8%) 5 (25.0%) 12 (37.5%) 0.1
Atheroma 13 (48.2%) 7 (35.0%) 9 (28.1%) 0.2
Diabetes 8 (29.6%) 10 (50.0%) 9 (28.1%) 0.2
Cardiovascular diseases 14 (51.9%) 14 (70.0%) 27 (84.4%) 0.02
Respiratory diseases 17 (63%) 9 (45.0%) 21 (65.6%) 0.3
Chronic kidney disease 13 (48.2%) 15 (75.0%) 32 (71.9%) 0.08
Neoplastic disease 11 (40.7%) 6 (30.0%) 14 (43.8%) 0.4
Charlson Comorbidity Index 7.3 ± 0.3 * 8.3 ± 0.7 8.9 ± 0.3 * 0.005
Malnutrition N (%)
No malnutrition 15 (19.0%) 5 (6.3%) 11 (13.9%) 0.2
Risk of malnutrition 9 (11.4%) 10 (12.7%) 13 (16.5%) 0.2
Malnutrition 3 (3.8%) 5 (6.3%) 8 (10.1%) 0.2
Frailty N (%)
Non-fragile 3 (3.8%) 0 (0.0%) 0 (0.0%) 0.01
Pre-fragile 10 (12.7%) 2 (2.5%) 3 (3.8%) 0.01
Fragile 14 (17.7%) 18 (22.8%) 29 (36.7%) 0.01

All categorical data are presented as numbers (percent). Age, BMI, and Charlson comorbidity index are expressed as mean ± standard error. The Kruskal–Wallis-Multiple comparison Z-value test (Dunn’s test) tested the difference between groups (age, BMI, Charlson comorbidity index), and similar symbol (Asterisk *) indicates statistical significance between groups. Pearson’s chi-squared test was used for categorical data. Abbreviations: BMI, body mass index; N, number of subjects.